|
SLC25A17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63336011382853E-12 |
| Normal-vs-Stage2 |
6.70409999736776E-08 |
| Normal-vs-Stage3 |
4.03940003668168E-09 |
| Normal-vs-Stage4 |
6.6559999956084E-08 |
| Stage1-vs-Stage2 |
7.629600E-01 |
| Stage1-vs-Stage3 |
8.379600E-01 |
| Stage1-vs-Stage4 |
3.635000E-01 |
| Stage2-vs-Stage3 |
6.900400E-01 |
| Stage2-vs-Stage4 |
2.642000E-01 |
| Stage3-vs-Stage4 |
4.795000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6251444634463E-12 |
| Normal-vs-AfricanAmerican |
9.75070024722413E-11 |
| Normal-vs-Asian |
2.177900E-04 |
| Caucasian-vs-AfricanAmerican |
8.543600E-01 |
| Caucasian-vs-Asian |
8.874600E-01 |
| AfricanAmerican-vs-Asian |
8.484800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62470037423645E-12 |
| Normal-vs-Female |
4.00150024226775E-10 |
| Male-vs-Female |
3.142600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.04813943582849E-12 |
| Normal-vs-Extreme_Weight |
1.64512847788956E-12 |
| Normal-vs-Obese |
6.07920380701898E-11 |
| Normal-vs-Extreme_Obese |
9.357000E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.697600E-01 |
| Normal_Weight-vs-Obese |
3.448600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.365200E-01 |
| Extreme_Weight-vs-Obese |
4.371400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.015000E-01 |
| Obese-vs-Extreme_Obese |
7.437200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.59940000005388E-06 |
| Normal-vs-Age(41-60Yrs) |
2.1271873151818E-13 |
| Normal-vs-Age(61-80Yrs) |
4.50750547997814E-14 |
| Normal-vs-Age(81-100Yrs) |
1.06030000335267E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.506200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.273200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.510000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.170400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.648400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.914370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64823710235851E-12 |
| Normal-VS-Type2 PRCC |
4.57411886145564E-14 |
| Normal-VS-KIRP CIMP |
1.627760E-04 |
| Normal-VS-Unclassified PRCC |
3.88489240776835E-12 |
| Type1 PRCC-VS-Type2 PRCC |
5.898400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.221000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.271770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.563750E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.843200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.943990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.21409565628983E-13 |
| Normal-vs-N1 |
7.05660000432928E-08 |
| Normal-vs-N2 |
5.039400E-03 |
| N0-vs-N1 |
6.360800E-01 |
| N0-vs-N2 |
6.569200E-01 |
| N1-vs-N2 |
8.706000E-01 |
|
|
